Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy

Author:

Figlioli GisellaORCID,De Nicolo Arcangela,Catucci Irene,Manoukian Siranoush,Peissel BernardORCID,Azzollini JacopoORCID,Beltrami BenedettaORCID,Bonanni Bernardo,Calvello MariarosariaORCID,Bondavalli DavideORCID,Pasini Barbara,Vignolo Lutati Francesca,Ogliara Paola,Zuradelli Monica,Pensotti ValeriaORCID,De Vecchi Giovanna,Volorio Sara,Verderio Paolo,Pizzamiglio SaraORCID,Matullo GiuseppeORCID,Aneli SerenaORCID,Birolo GiovanniORCID,Zanardi FedericaORCID,Tondini Carlo,Zambelli Alberto,Livraghi LucaORCID,Franchi Michela,Radice Paolo,Peterlongo PaoloORCID

Abstract

Germline pathogenic variants (PVs) in the BRCA1 or BRCA2 genes cause high breast cancer risk. Recurrent or founder PVs have been described worldwide including some in the Bergamo province in Northern Italy. The aim of this study was to compare the BRCA1/2 PV spectra of the Bergamo and of the general Italian populations. We retrospectively identified at five Italian centers 1019 BRCA1/2 PVs carrier individuals affected with breast cancer and representative of the heterogeneous national population. Each individual was assigned to the Bergamo or non-Bergamo cohort based on self-reported birthplace. Our data indicate that the Bergamo BRCA1/2 PV spectrum shows less heterogeneity with fewer different variants and an average higher frequency compared to that of the rest of Italy. Consistently, four PVs explained about 60% of all carriers. The majority of the Bergamo PVs originated locally with only two PVs clearly imported. The Bergamo BRCA1/2 PV spectrum appears to be private. Hence, the Bergamo population would be ideal to study the disease risk associated with local PVs in breast cancer and other disease-causing genes. Finally, our data suggest that the Bergamo population is a genetic isolate and further analyses are warranted to prove this notion.

Funder

Associazione Italiana per la Ricerca sul Cancro

Fondazione Umberto Veronesi

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3